Lbp Am Sa Sells 1,766 Shares of Cardinal Health, Inc. (NYSE:CAH)

LBP AM SA trimmed its position in shares of Cardinal Health, Inc. (NYSE:CAH - Free Report) by 3.3% during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 52,268 shares of the company's stock after selling 1,766 shares during the period. LBP AM SA's holdings in Cardinal Health were worth $7,201,000 as of its most recent SEC filing.

Other large investors also recently modified their holdings of the company. Cyrus J. Lawrence LLC purchased a new position in shares of Cardinal Health during the 4th quarter valued at about $26,000. Bellwether Advisors LLC bought a new position in Cardinal Health during the 4th quarter worth approximately $32,000. Tompkins Financial Corp increased its stake in Cardinal Health by 106.7% in the 1st quarter. Tompkins Financial Corp now owns 248 shares of the company's stock worth $34,000 after purchasing an additional 128 shares during the period. Lee Danner & Bass Inc. purchased a new position in Cardinal Health in the 4th quarter worth approximately $35,000. Finally, Itau Unibanco Holding S.A. bought a new stake in Cardinal Health in the fourth quarter valued at approximately $36,000. 87.17% of the stock is owned by hedge funds and other institutional investors.

Cardinal Health Stock Performance

Shares of CAH traded down $2.31 during trading hours on Thursday, hitting $161.95. The company had a trading volume of 2,223,606 shares, compared to its average volume of 2,245,370. The firm has a fifty day moving average price of $157.12 and a 200-day moving average price of $138.16. The stock has a market capitalization of $38.65 billion, a price-to-earnings ratio of 25.27, a P/E/G ratio of 1.63 and a beta of 0.68. Cardinal Health, Inc. has a 52-week low of $93.17 and a 52-week high of $168.44.

Cardinal Health (NYSE:CAH - Get Free Report) last issued its earnings results on Thursday, May 1st. The company reported $2.35 earnings per share for the quarter, topping analysts' consensus estimates of $2.15 by $0.20. Cardinal Health had a negative return on equity of 68.84% and a net margin of 0.70%. The business had revenue of $54.88 billion during the quarter, compared to analyst estimates of $55.33 billion. During the same quarter in the previous year, the firm earned $2.08 EPS. Cardinal Health's revenue was up .0% on a year-over-year basis. Research analysts anticipate that Cardinal Health, Inc. will post 7.95 earnings per share for the current fiscal year.

Cardinal Health Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, July 15th. Stockholders of record on Tuesday, July 1st will be paid a $0.5107 dividend. This represents a $2.04 annualized dividend and a dividend yield of 1.26%. The ex-dividend date of this dividend is Tuesday, July 1st. This is a boost from Cardinal Health's previous quarterly dividend of $0.51. Cardinal Health's dividend payout ratio is 31.83%.

Analysts Set New Price Targets

Several equities analysts have recently commented on CAH shares. Bank of America upped their price objective on shares of Cardinal Health from $165.00 to $170.00 and gave the company a "buy" rating in a research note on Tuesday, June 10th. Wall Street Zen raised shares of Cardinal Health from a "buy" rating to a "strong-buy" rating in a research note on Monday, May 5th. Morgan Stanley set a $181.00 price objective on shares of Cardinal Health and gave the company an "overweight" rating in a research report on Friday, June 13th. Mizuho boosted their price objective on shares of Cardinal Health from $142.00 to $150.00 and gave the company an "outperform" rating in a research report on Monday, March 31st. Finally, Wells Fargo & Company raised shares of Cardinal Health from an "equal weight" rating to an "overweight" rating and boosted their price objective for the company from $136.00 to $179.00 in a research report on Tuesday, June 3rd. Three research analysts have rated the stock with a hold rating, eleven have issued a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat, the company currently has an average rating of "Moderate Buy" and an average price target of $157.43.

About Cardinal Health

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.